TCIM
AVNR

TIAA CREF Investment Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

TIAA CREF Investment Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-784,190
Closed -$13.3M – 3158
2014
Q4 		$13.3M Buy
784,190
+79,261
+11% +$1.12M 0.01% 936
2014
Q3 		$8.4M Buy
704,929
+8,146
+1% +$55.6K 0.01% 1214
2014
Q2 		$3.93M Buy
696,783
+40,071
+6% +$185K ﹤0.01% 1851
2014
Q1 		$2.41M Buy
656,712
+84,241
+15% +$321K ﹤0.01% 2127
2013
Q4 		$1.92M Sell
572,471
-12,160
-2% -$50.2K ﹤0.01% 2279
2013
Q3 		$2.48M Sell
584,631
-16,196
-3% -$76.7K ﹤0.01% 2076
2013
Q2 		$2.76M Buy
+600,827
New +$2.07M ﹤0.01% 1957

TIAA CREF Investment Management's AVNR Position: Q1 2015 in Review

TIAA CREF Investment Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 784,190 shares — an estimated $13.3M sold.

TIAA CREF Investment Management first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $13.3M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • TIAA CREF Investment Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • TIAA CREF Investment Management sold 784,190 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $13.3M.
  • TIAA CREF Investment Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • TIAA CREF Investment Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $13.3M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on TIAA CREF Investment Management's 13F filing for Q1 2015, filed 5 May 2015.